- Tytuł:
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- Autorzy:
- Źródło:
- In The Lancet Oncology June 2021 22(6):765-778
Czasopismo naukowe